Pharmacogenetics in Psychiatry
作者： Evangelia M. Tsapakis , Sarah Curran , Ruth I. Ohlsen , Nora S. Vyas , Katherine J. Aitchison
DOI: 10.1002/9781118116494.CH7
关键词:
摘要: … , other relevant targets have been studied, such as the serotonergic 5HT2A (HTR2A), 5HT2C (HTR2C), and 5HT6 (HTR6) receptors, the histaminergic H1 and H2 receptors (HRH1 and …
sci-hub.se 参考文章(269)
Y Yamanouchi, N Iwata, T Suzuki, T Kitajima, M Ikeda, N Ozaki, Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone. Pharmacogenomics Journal. ,vol. 3, pp. 356- 361 ,(2003) , 10.1038/SJ.TPJ.6500211
Udo Bonnet, Moclobemide: Therapeutic Use and Clinical Studies Cns Drug Reviews. ,vol. 9, pp. 97- 140 ,(2003) , 10.1111/J.1527-3458.2003.TB00245.X
G Turecki, P Grof, P Cavazzoni, A Duffy, E Grof, B Ahrens, A Berghöfer, B Müller-Oerlinghausen, M Dvoráková, E Libigerová, M Vojtechovský, P Zvolský, R Joober, A Nilsson, H Prochazka, R W Licht, N A Rasmussen, M Schou, P Vestergaard, A Holzinger, C Schumann, K Thau, G A Rouleau, M Alda, Evidence for a role of phospholipase C-γ1 in the pathogenesis of bipolar disorder Molecular Psychiatry. ,vol. 3, pp. 534- 538 ,(1998) , 10.1038/SJ.MP.4000447
Vidar M. Steeir, Roger L??vlie, Yamima Osher, Robert H. Belmaker, Jan ??. Berle, Anne-Karin Gulbrandsen, The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness. Pharmacogenetics. ,vol. 8, pp. 259- 268 ,(1998) , 10.1097/00008571-199806000-00008
Hsien-Yuan Lane, Shih-Kuan Hsu, Yi-Ching Liu, Yue-Cune Chang, Chiung-Hsien Huang, Wen-Ho Chang, Dopamine D3 receptor Ser9Gly polymorphism and risperidone response. Journal of Clinical Psychopharmacology. ,vol. 25, pp. 6- 11 ,(2005) , 10.1097/01.JCP.0000150226.84371.76
Sylvie Lemonde, Lisheng Du, David Bakish, Pavel Hrdina, Paul R. Albert, Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response. The International Journal of Neuropsychopharmacology. ,vol. 7, pp. 501- 506 ,(2004) , 10.1017/S1461145704004699
Joseph T. Birkett, Maria J. Arranz, Janet Munro, Sarah Osbourn, Robert W. Kerwin, David A Collier, Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport. ,vol. 11, pp. 2017- 2020 ,(2000) , 10.1097/00001756-200006260-00042
Enrico Lattuada, Roberto Cavallaro, Alessandro Serretti, Cristina Lorenzi, Enrico Smeraldi, Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment. The International Journal of Neuropsychopharmacology. ,vol. 7, pp. 489- 493 ,(2004) , 10.1017/S1461145704004614
Gavin P. Reynolds, ZhiJian Yao, XiaoBin Zhang, Jing Sun, ZhiJun Zhang, Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response European Neuropsychopharmacology. ,vol. 15, pp. 143- 151 ,(2005) , 10.1016/J.EURONEURO.2004.07.001
Rhee-Hun Kang, Sang-Woo Hahn, Myoung-Jin Choi, Min-Soo Lee, Relationship between G-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression. Neuropsychobiology. ,vol. 56, pp. 1- 5 ,(2007) , 10.1159/000109970